The law offices of frank r. cruz announces investigation of revance therapeutics, inc. (rvnc) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of revance therapeutics, inc. (“revance” or the “company”) (nasdaq: rvnc) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on september 23, 2024, revance disclosed in a filing with the u.s. securities and exchange commission that it had "received a notice to remedy alleged material breach.
RVNC Ratings Summary
RVNC Quant Ranking